Dr. Donohue conducts research in the areas of pharmaceutical policy and mental health, and has particular expertise in the Affordable Care Act. She currently is conducting research on the impact of pharmacy insurance benefits on prescription drug utilization and expenditures. A major focus of this work is evaluating the impact of the new Medicare drug benefit (Part D) on medication access among elderly and disabled Medicare beneficiaries.
Other areas of expertise include doctor-patient communication on prescription drugs, the cost-effectiveness of mental health interventions, efforts to provide information on comparative effectiveness and prices of prescription drugs to consumers, direct-to-consumer advertising and other forms of pharmaceutical promotion.
Dr. Donohue received her PhD in health policy from Harvard University and completed a post-doctoral fellowship in pharmaceutical policy research at Harvard Medical School.